4.7 Article

An event-based model for disease progression and its application in familial Alzheimer's disease and Huntington's disease

Journal

NEUROIMAGE
Volume 60, Issue 3, Pages 1880-1889

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.neuroimage.2012.01.062

Keywords

Disease progression; MRI; Alzheimer's disease; Huntington's disease

Funding

  1. CHDI Foundation, Inc.
  2. EPSRC (UK) [EP/D506468/01, EP/E007748]
  3. TSB [M1638A]
  4. CBRC [168]
  5. Alzheimer's Society
  6. MRC (UK)
  7. National Institute for Health Research through North Thames Dementias and Neurodegenerative Research Network, DeNDRoN
  8. Department of Health's NIHR Biomedical Research Centres
  9. Alzheimer's Research UK
  10. Alzheimers Research UK [ART-EG2010B-1] Funding Source: researchfish
  11. Engineering and Physical Sciences Research Council [EP/G007748/1] Funding Source: researchfish
  12. Medical Research Council [G0601846] Funding Source: researchfish
  13. National Institute for Health Research [NF-SI-0508-10123] Funding Source: researchfish
  14. EPSRC [EP/G007748/1] Funding Source: UKRI
  15. MRC [G0601846] Funding Source: UKRI

Ask authors/readers for more resources

Understanding the progression of neurological diseases is vital for accurate and early diagnosis and treatment planning. We introduce a new characterization of disease progression, which describes the disease as a series of events, each comprising a significant change in patient state. We provide novel algorithms to learn the event ordering from heterogeneous measurements over a whole patient cohort and demonstrate using combined imaging and clinical data from familial Alzheimer's and Huntington's disease cohorts. Results provide new detail in the progression pattern of these diseases, while confirming known features, and give unique insight into the variability of progression over the cohort. The key advantage of the new model and algorithms over previous progression models is that they do not require a priori division of the patients into clinical stages. The model and its formulation extend naturally to a wide range of other diseases and developmental processes and accommodate cross-sectional and longitudinal input data. (C) 2012 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available